Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Leucettinib-92
130
CHF
CHF 130.00
In stock
AG-MR-C0049-M0011 mgCHF 130.00
AG-MR-C0049-M0055 mgCHF 430.00
AG-MR-C0049-M02525 mgCHF 1'290.00
NEW
![Loading...](https://adipogen.com/pub/static/version1703841973/frontend/raffiniert/adipogen/de_CH/images/loader-1.gif)
Product Details | |
---|---|
Synonyms | LCTB-92; (Z)-2-((Adamantan-1-yl)amino)-5-(benzo[d]thiazol-6-ylmethylene)-3,5-dihydro-4H-imidazol-4-one |
Product Type | Chemical |
Properties | |
Formula |
C21H22N4OS |
MW | 378.5 |
CAS | 2732859-57-1 |
Purity Chemicals | ≥99% (NMR) |
Appearance | Pale yellow to off-white powder. |
Solubility | Soluble in DMSO (10mM) or ethanol. |
Reconstitution | Stock solutions can be made up to 10mM in DMSO. |
Identity | Determined by 1H-NMR. |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice |
Keep cool and dry. Protect from light and moisture. |
Use/Stability |
Stable for at least 2 years after receipt when stored at -20°C. Store solutions at -20°C in the dark. |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet |
![]() |
Description
- Potent inhibitor of DYRK1A (IC50=1.2nM), DYRK1B (IC50=1.8nM), DYRK3 (IC50=19.3nM) and CLK2 (IC50=0.6nM) [1].
- Inhibits the phosphorylation of Tau at Thr212 and cyclin D1 at Thr286.
- Corrects cognitive deficits in animal models of Down syndrome.
- iso-Leucettinib-92 (Prod. No. AG-MR-C0050) is a kinase-inactive isomer and should be used as a negative control together with this compound.
Product References
- Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases: M.F. Lindberg, et al.; J. Med. Chem. 66, 4106 (2023)
- Leucettinibs, a Class of DYRK/CLK Kinase Inhibitors Inspired by the Marine Sponge Natural Product Leucettamine B: E. Deau, et al.; J. Med. Chem. 66, 10694 (2023)